To mark the 25th edition of the Euromelanoma campaign, promoted by the Healthy Skin Foundation of the Spanish Academy of Dermatology and Venereology1
Susana Puig, the head of the IDIBAPS research group Melanoma: imaging, genetics and immunology (ubicated at Esther Koplowitz Centre) of the Dermatolo1
Conducted as part of the MELCAYA project, the study demonstrates that anti PD-1 antibody immunotherapy is safe for children and adolescents. Furtherm1
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet’s1
It was observed that the lifeguards received over 20 times the safe dose of UV radiation in a single day. The study results allowed the observation c1
Endowed with eight million euros, the project is coordinated by Susana Puig, the head of the research group IDIBAPS Melanoma: imaging, genetics and i1
